Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis
This study is currently recruiting participants.
Verified May 2013 by Yuhan Corporation
Study NCT01538849   Information provided by Yuhan Corporation

First Received on February 20, 2012.   Last Updated on May 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Reflux Esophagitis
Additional conditions recognized in this trial
Esophagitis
Esophagitis, Peptic
Gastroesophageal Reflux
More general conditions related to this trial
Deglutition Disorders
Digestive System Diseases
Esophageal Diseases
Esophageal Motility Disorders
Gastroenteritis
Gastrointestinal Diseases
Peptic Ulcer
Interventions listed in this trial
Esomeprazole 40mg
YH4808 A mg
YH4808 B mg
YH4808 C mg
Additional drug interventions recognized in this trial
Omeprazole
More general drug interventions related to this trial
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Yuhan Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services